Your browser doesn't support javascript.
loading
Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia.
Hansson, Lotta; Asklid, Anna; Diels, Joris; Eketorp-Sylvan, Sandra; Repits, Johanna; Søltoft, Frans; Jäger, Ulrich; Österborg, Anders.
  • Hansson L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. lotta.hansson@karolinska.se.
  • Asklid A; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden. lotta.hansson@karolinska.se.
  • Diels J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Eketorp-Sylvan S; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
  • Repits J; Janssen EMEA, Beerse, Belgium.
  • Søltoft F; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Jäger U; Janssen Nordic, Stockholm, Sweden.
  • Österborg A; Janssen Nordic, Stockholm, Sweden.
Ann Hematol ; 96(10): 1681-1691, 2017 Oct.
Article en En | MEDLINE | ID: mdl-28762081
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Leucemia Linfocítica Crónica de Células B Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Leucemia Linfocítica Crónica de Células B Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article